Prospective OCT Study With Lucentis for Neovascular AMD (PrONTO Study)

Part of paid clinical trials in Miami, Florida.

Sponsor
University of Miami
Study ID
NCT00344227
Phase
PHASE2
Status
Completed

Conditions

  • Neovascular Age-Related Macular Degeneration

Eligibility Criteria

Sex
ALL
Age
50 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

The PrONTO Study was designed to evaluate the response of neovascular age-related macular degeneration (AMD) patients to intravitreal Lucentis using Optical Coherence Tomography (OCT) imaging. OCT was then used to determine the need for retreatment after 3 monthly injections of Lucentis. Patients would be followed for 2 years.

Key Dates

First listed
Jun 26, 2006
Start date
Aug 31, 2004
Status verified
Jun 2006
Completion
Apr 30, 2007

Study Design

Enrollment
40 participants
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Primary Outcome Measure

Mean Visual Acuity

Locations (1)

FacilityCityStateZIPSite coordinators
Bascom Palmer Eye InstituteMiamiFlorida33136-

Find similar trials in Miami, FL

By research site
Bascom Palmer Eye Institute· Miami, FL

Related Studies